Chang H X, Chou T C, Savaraj N, Liu L F, Yu C, Cheng C C
Drug Development Laboratory, Department of Pharmacology, Toxicology & Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas 66160-7419, USA.
J Med Chem. 1999 Feb 11;42(3):405-8. doi: 10.1021/jm9804679.
The intermediate in the preparation of 1,3,7, 10-tetrahydroxybenzo[b]naphtho[2,3-d]furan-6,11-dione (2), 2-chloro-5,8-dimethoxy-3-(3,5-dimethoxyphenoxy)-1,4-naphthoquinone (8h), and corresponding hydroxyl, methoxyl, and acetoxyl analogues was found to possess interesting inhibitory activities in a number of cytotoxic test systems. Activities were also noticed in some 5, 8-dihydroxy-1,4-naphthoquinone derivatives. A structure-activity discussion of compounds of this series is presented. The newly uncovered biological activity of 2-chloro-3-(substituted phenoxyl)-1, 4-naphthoquinones and 2,3-bis(substituted phenoxy)-1, 4-naphthoquinones may suggest an approach for the development of new classes of antineoplastic agents.
在制备1,3,7,10 - 四羟基苯并[b]萘并[2,3 - d]呋喃 - 6,11 - 二酮(2)、2 - 氯 - 5,8 - 二甲氧基 - 3 -(3,5 - 二甲氧基苯氧基)- 1,4 - 萘醌(8h)以及相应的羟基、甲氧基和乙酰氧基类似物的过程中,发现中间体在许多细胞毒性测试系统中具有有趣的抑制活性。在一些5,8 - 二羟基 - 1,4 - 萘醌衍生物中也观察到了活性。本文对该系列化合物进行了构效关系讨论。新发现的2 - 氯 - 3 -(取代苯氧基)- 1,4 - 萘醌和2,3 - 双(取代苯氧基)- 1,4 - 萘醌的生物活性可能为开发新型抗肿瘤药物提供一种途径。